Aurenar is creating a unique, disposable, wearable neuromodulation device that is changing the arc of care of critically ill patients.

Enso Vascular is developing a first-of-its-kind topical patch that prepares the vascular access site before needle insertion — minimizing pain and reducing vessel spasm and access complications across hundreds of millions of procedures.

Fluid Biomed is commercializing the first polymer-based brain stent to cure aneurysms. Brain aneurysms afflict up to 5% of people and can lead to devastating stroke. The company team of neurosurgeons, scientists, and engineers has designed the world’s first hybrid polymer-metal flow-diverting stent to cure this deadly disease.

Hyperion is bringing AI-guided, robot-assisted precision to one of medicine’s most common procedures - its IVY platform performed the world’s first robotic-assisted IV catheterization.

Creating a bridge between humans and machines for the enhancement of people’s lives.

Comprehensive virtual care for people who have experienced a stroke. Precision Recovery is helping patients feel safe, connected and in control of their recovery from the comfort of their home.

Proprio is a technology company modernizing the way we predict, perform, and perfect surgery through the combination of physician expertise and immersive, intelligent technology.

Radical is reinventing the neurovascular catheter with a novel “ribbon” construction that delivers flexibility, pushability, and stability at once - reaching further into tortuous anatomy without compromise.

A breakthrough technology to directly restore shoulder, arm, and hand movement for stroke survivors.

A Cornell nanomedicine spinout, TETmedical is building NSE-FAST - a first-of-its-kind blood-based diagnostic to detect brain injury from stroke, powered by its tethered-enzyme “nanobot.”

Von Vascular, Inc. is at the forefront of medical device innovation, dedicated to transforming thrombectomy with groundbreaking technologies.